0 731

Cited 0 times in

Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients

DC Field Value Language
dc.contributor.author김동익-
dc.contributor.author김동준-
dc.contributor.author김응엽-
dc.contributor.author변준수-
dc.contributor.author서상현-
dc.contributor.author이경열-
dc.contributor.author정진영-
dc.contributor.author허지회-
dc.date.accessioned2015-05-19T16:36:44Z-
dc.date.available2015-05-19T16:36:44Z-
dc.date.issued2008-
dc.identifier.issn0284-1851-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/106623-
dc.description.abstractBACKGROUND: Mechanical thrombolysis may effectively enhance the efficacy of thrombolysis for hyperacute ischemic stroke patients. PURPOSE: To assess the feasibility and results of simple mechanical-based thrombolysis using microwire and microcatheter with adjuvant low-dose intraarterial (i.a.) urokinase (UK) for the treatment of hyperacute ischemic stroke. MATERIAL AND METHODS: Nineteen consecutive patients with hyperacute proximal middle cerebral artery (MCA) occlusions treated by a standardized protocol using microwire and microcatheter for mechanical thrombus disruption with adjuvant i.a. UK were reviewed. Simple to-and-fro passages through the clot with the microwire and microcatheter followed by disruptions by a J- or pigtail-shaped wire tip with alternating small-dose injections of UK distal, within, and proximal to the clot were performed. The recanalization rates, post-thrombolysis hemorrhage, and clinical outcome (baseline and discharge National Institute of Health Stroke Scale [NIHSS], mortality, 3-month modified Rankin scale [mRS]) were evaluated. RESULTS: Recanalization was achieved in 18 of 19 patients (94.7%). The mean UK dose was 375,789 IU (range 130,000-580,000 IU). Two patients (10.5%) developed symptomatic hemorrhage. One of the hemorrhages included a patient who developed subarachnoid hemorrhage. Mortality rate was 15.8% (n = 3). The median baseline NIHSS scores showed improvement from 17 to 10 at presentation and discharge, respectively. At three months, good outcome was noted in 11 of 19 patients (57.9%, mRS 0-2). CONCLUSION: Simple mechanical-based thrombolysis using microwire and microcatheter with adjuvant low-dose i.a. UK is safe and effective in achieving recanalization with good long-term outcome.-
dc.description.statementOfResponsibilityopen-
dc.format.extent351~357-
dc.relation.isPartOfACTA RADIOLOGICA-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAcute Disease-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCatheterization/instrumentation*-
dc.subject.MESHChemotherapy, Adjuvant-
dc.subject.MESHCombined Modality Therapy/adverse effects-
dc.subject.MESHCombined Modality Therapy/instrumentation-
dc.subject.MESHCombined Modality Therapy/methods-
dc.subject.MESHFeasibility Studies-
dc.subject.MESHFemale-
dc.subject.MESHFibrinolytic Agents/administration & dosage-
dc.subject.MESHFibrinolytic Agents/adverse effects-
dc.subject.MESHFibrinolytic Agents/therapeutic use*-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHInfarction, Middle Cerebral Artery/drug therapy*-
dc.subject.MESHInjections, Intra-Arterial-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHProspective Studies-
dc.subject.MESHThrombolytic Therapy/adverse effects-
dc.subject.MESHThrombolytic Therapy/instrumentation*-
dc.subject.MESHThrombolytic Therapy/methods-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUrokinase-Type Plasminogen Activator/administration & dosage-
dc.subject.MESHUrokinase-Type Plasminogen Activator/adverse effects-
dc.subject.MESHUrokinase-Type Plasminogen Activator/therapeutic use*-
dc.titleSimple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Neurology (신경과학)-
dc.contributor.googleauthorKim DJ-
dc.contributor.googleauthorKim DI-
dc.contributor.googleauthorByun JS-
dc.contributor.googleauthorJung JY-
dc.contributor.googleauthorSuh SH-
dc.contributor.googleauthorKim EY-
dc.contributor.googleauthorLee KY-
dc.contributor.googleauthorHeo JH-
dc.identifier.doi10.1080/02841850701819143-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00408-
dc.contributor.localIdA00410-
dc.contributor.localIdA00832-
dc.contributor.localIdA01858-
dc.contributor.localIdA01886-
dc.contributor.localIdA02648-
dc.contributor.localIdA04369-
dc.relation.journalcodeJ00033-
dc.identifier.eissn1600-0455-
dc.identifier.pmid18365826-
dc.identifier.urlhttp://acr.sagepub.com/content/49/3/351.abstract-
dc.subject.keywordCNS, interventional-
dc.subject.keywordischemia/infarction-
dc.subject.keywordthrombolysis-
dc.contributor.alternativeNameKim, Dong Ik-
dc.contributor.alternativeNameKim, Dong Joon-
dc.contributor.alternativeNameKim, Eung Yeop-
dc.contributor.alternativeNameByun, Joon Soo-
dc.contributor.alternativeNameSuh, Sang Hyun-
dc.contributor.alternativeNameLee, Kyung Yul-
dc.contributor.alternativeNameJung, Jin Young-
dc.contributor.alternativeNameHeo, Ji Hoe-
dc.contributor.affiliatedAuthorKim, Dong Ik-
dc.contributor.affiliatedAuthorKim, Dong Joon-
dc.contributor.affiliatedAuthorKim, Eung Yeop-
dc.contributor.affiliatedAuthorByun, Joon Soo-
dc.contributor.affiliatedAuthorSuh, Sang Hyun-
dc.contributor.affiliatedAuthorLee, Kyung Yul-
dc.contributor.affiliatedAuthorHeo, Ji Hoe-
dc.rights.accessRightsnot free-
dc.citation.volume49-
dc.citation.number3-
dc.citation.startPage351-
dc.citation.endPage357-
dc.identifier.bibliographicCitationACTA RADIOLOGICA, Vol.49(3) : 351-357, 2008-
dc.identifier.rimsid46153-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.